Cargando…

Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors

Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs (ncRNAs) >200 nucleotides in length that govern diverse biological processes. Recent evidence suggests that lncRNAs are involved in cancer cell proliferation, apoptosis, invasion, migration, and metastasis. Dysregulation of lncRNAs has...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhonghua, Huang, Hesuyuan, Xu, Yetao, He, Xuezhi, Wang, Jirong, Hui, Bingqing, Ji, Hao, Zhou, Jing, Wang, Keming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626378/
https://www.ncbi.nlm.nih.gov/pubmed/29026319
http://dx.doi.org/10.2147/OTT.S136915
_version_ 1783268534387736576
author Ma, Zhonghua
Huang, Hesuyuan
Xu, Yetao
He, Xuezhi
Wang, Jirong
Hui, Bingqing
Ji, Hao
Zhou, Jing
Wang, Keming
author_facet Ma, Zhonghua
Huang, Hesuyuan
Xu, Yetao
He, Xuezhi
Wang, Jirong
Hui, Bingqing
Ji, Hao
Zhou, Jing
Wang, Keming
author_sort Ma, Zhonghua
collection PubMed
description Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs (ncRNAs) >200 nucleotides in length that govern diverse biological processes. Recent evidence suggests that lncRNAs are involved in cancer cell proliferation, apoptosis, invasion, migration, and metastasis. Dysregulation of lncRNAs has been observed in various tumors, and lncRNAs act as oncogenes or tumor suppressors in these malignancies. It has been revealed that lncRNA highly upregulated in liver cancer (HULC) is tightly correlated with a number of cancers such as hepatocellular carcinoma, gastric cancer, colorectal cancer, osteosarcoma, and diffuse large B-cell lymphoma. Depletion of HULC suppressed cancer cell proliferation, migration, and invasion and induced apoptosis. Additionally, HULC may function as a diagnostic biomarker and prognostic indicator for some tumors. In this review, we summarize the current knowledge of the role of HULC in cancer progression and the clinical management of human cancers.
format Online
Article
Text
id pubmed-5626378
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56263782017-10-12 Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors Ma, Zhonghua Huang, Hesuyuan Xu, Yetao He, Xuezhi Wang, Jirong Hui, Bingqing Ji, Hao Zhou, Jing Wang, Keming Onco Targets Ther Review Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs (ncRNAs) >200 nucleotides in length that govern diverse biological processes. Recent evidence suggests that lncRNAs are involved in cancer cell proliferation, apoptosis, invasion, migration, and metastasis. Dysregulation of lncRNAs has been observed in various tumors, and lncRNAs act as oncogenes or tumor suppressors in these malignancies. It has been revealed that lncRNA highly upregulated in liver cancer (HULC) is tightly correlated with a number of cancers such as hepatocellular carcinoma, gastric cancer, colorectal cancer, osteosarcoma, and diffuse large B-cell lymphoma. Depletion of HULC suppressed cancer cell proliferation, migration, and invasion and induced apoptosis. Additionally, HULC may function as a diagnostic biomarker and prognostic indicator for some tumors. In this review, we summarize the current knowledge of the role of HULC in cancer progression and the clinical management of human cancers. Dove Medical Press 2017-09-25 /pmc/articles/PMC5626378/ /pubmed/29026319 http://dx.doi.org/10.2147/OTT.S136915 Text en © 2017 Ma et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Ma, Zhonghua
Huang, Hesuyuan
Xu, Yetao
He, Xuezhi
Wang, Jirong
Hui, Bingqing
Ji, Hao
Zhou, Jing
Wang, Keming
Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title_full Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title_fullStr Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title_full_unstemmed Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title_short Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
title_sort current advances of long non-coding rna highly upregulated in liver cancer in human tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626378/
https://www.ncbi.nlm.nih.gov/pubmed/29026319
http://dx.doi.org/10.2147/OTT.S136915
work_keys_str_mv AT mazhonghua currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT huanghesuyuan currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT xuyetao currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT hexuezhi currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT wangjirong currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT huibingqing currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT jihao currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT zhoujing currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors
AT wangkeming currentadvancesoflongnoncodingrnahighlyupregulatedinlivercancerinhumantumors